Telisotuzumab vedotin (anti-c-Met) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin (anti-c-Met) consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin (anti-c-Met) can be used in cancer research.Purity:>90% (SDS-PAGE&SEC):Endotoxin Level:< 1.0EU/mg.
Specifications and Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
- UPC:
- 51152004
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab183336-1mg
- CAS:
- 1714088-51-3
- Product Size:
- 1mg
akash.verma@cenmed.com
(732) 447-1115





